Welcome to our dedicated page for IDT SEC filings (Ticker: IDT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IDT Corporation filings document formal disclosures for a global fintech and communications operating company with Class B common stock listed on the New York Stock Exchange. Recent Form 8-K reports furnish quarterly and annual operating results, earnings-release exhibits and Regulation FD disclosures tied to dividends and other material corporate updates.
Proxy materials and annual-meeting reports cover board elections, stockholder voting results and equity incentive plan matters. The filing record also identifies recurring disclosure subjects for IDT’s business portfolio, including National Retail Solutions, Fintech, net2phone, Traditional Communications, remittance services, digital payments, cloud communications and international voice and SMS messaging.
IDT has a notice of proposed sale under Form 144 covering 9,877 shares of Class B Common stock, to be sold through Morgan Stanley Smith Barney LLC on or after July 15, 2026 on the NYSE.
The shares trace to restricted stock that vested under registered plans on several dates, including 5,216 shares on December 5, 2024; 2,661 shares on May 17, 2023; and smaller grants. These awards were issued by the company as compensation for services rendered.
IDT CORP director Eric F. Cosentino reported an open-market sale of 500 shares of Class B Common Stock at $57.7800 per share. After this transaction, he directly holds 539 shares. According to the footnote, these holdings consist of fully vested shares of restricted stock.
IDT Corp Chief Financial Officer Marcelo Fischer reported an open-market sale of Class B Common Stock. On June 26, 2026, he sold 23,323 shares of Class B Common Stock at an average price of $56.9834 per share.
After this transaction, Fischer directly held 32,824 shares of Class B Common Stock. He also had an additional 2,760 shares held indirectly through a 401(k) plan as of May 29, 2026, showing both direct and retirement-plan exposure to IDT equity.
The issuer has a Class B Common position of 500 shares connected to restricted stock that vested on 01/05/2026. The filing lists these 500 shares for sale with broker information showing Morgan Stanley Smith Barney LLC and an associated date of 06/30/2026.
IDT reported a proposed sale of 23,323 shares of Class B Common under Rule 144, with a related past three‑month sale of 5,000 shares for $252,500. The filing lists the transaction as Restricted Stock Vesting Under a Registered Plan with dates shown on the form.
IDT CORP chairman Howard S. Jonas reported a small charitable-style transfer of stock. On June 23, 2026, he made a bona fide gift of 2,217 shares of Class B Common Stock at a stated price of $0.00 per share, leaving 46,553 Class B shares held directly.
The filing also lists multiple indirect holdings as of May 29, 2026, including 1,574,326 Class A shares held by IDT A Partners, L.P. and several Class B positions through a 401(k) plan, family trusts, a foundation, and Chartwell Holding LLC. No option or other derivative positions are shown.
IDT CORP former director Irwin Katsof sold his remaining Class B Common Stock in an open-market transaction. On June 11, 2026, he sold 2,408 shares at an average price of $55.0272 per share. Following this sale, the filing shows he directly owns 0 shares of this class.
IDT Corporation reported a board change, with director Irwin Katsof resigning and the board appointing William Conkling as a new independent director. The company stated that Katsof’s resignation was not due to any disagreement over operations, policies, or practices.
Conkling will serve on the board until the 2026 annual meeting and is expected to chair the Audit Committee, act as the Audit Committee Financial Expert, and sit on the Compensation and Corporate Governance Committees. He brings senior commercial and leadership experience from Protara Therapeutics, Rafael Holdings, Immunomedics, and Novartis.
IDT Corporation submitted a Form 144 notice relating to proposed sales of Class B Common shares through Morgan Stanley Smith Barney. The filing lists scheduled vesting events for restricted shares: 369 shares vested 12/12/2024, 1,053 shares vested 01/06/2025, and 986 shares vesting 01/05/2026. The filing references broker details and a transaction date of 06/11/2026.
CONKLING WILLIAM reported acquisition or exercise transactions in this Form 4 filing.
IDT CORP director William Conkling received a grant of 673 shares of Class B Common Stock as restricted stock that vested immediately. The award price was $55.75 per share, and following this grant he directly holds 673 fully vested shares. This is a compensation-related equity award, not an open-market purchase.